NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

RecruitingPhase 1

Sponsor: Stephanie B. Seminara, MD

Conditions: Reproductive Disorder, Neurodegeneration, SARS-CoV 2, Long COVID

Interventions: Kisspeptin 112-121

Countries: United States

The objective of this protocol is to use a case-control paradigm to compare the response to an intravenous administration of kisspeptin in individuals with and without post-covid-19 syndrome. The study subjects will receive a single bolus of kisspeptin.

Eligibility overview

Sex: ALL

Age: 18 Years to 60 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

* Female (ages 18-45 years) or Male (ages 18-60 years)
* No current or recent use of a medication (including hormonal replacement) that, in the opinion of a study investigator, can modulate the reproductive axis or willing to complete an appropriate washout for that particular medication and its method of administration
* For women, negative serum hCG pregnancy test
* For cases, diagnosis of post-covid-19 syndrome
* For controls, history of prior covid infection but no diagnosis of post-covid-19 syndrome

Exclusion Criteria

* Any condition (medical, mental, or behavioral) that, in the opinion of a study investigator, would likely interfere with participation in/completion of the protocol or the interpretation of results
* Active use of illicit drugs (not including marijuana)
* For women,
* Pregnant
* Trying to become pregnant during protocol participation
* Breast feeding
* Surgical or natural menopause

Locations (1)

Boston, Massachusetts, United States